SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387308-14-000113
Filing Date
2014-08-19
Accepted
2014-08-19 15:37:07
Documents
5
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q (6-30-14) form10q.htm 10-Q 424892
2 EX 31.1 ex331.htm EX-31.1 9883
3 EX 32.1 ex321.htm EX-32.1 5710
4 EX 3.3 certificateofamendment.pdf EX-3.3 11101738
5 EX 3.3 certificateofamendment.htm EX-3.3 511
  Complete submission text file 0001387308-14-000113.txt   15738011
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 141051976
SIC: 4953 Refuse Systems